# Safety and Effectiveness of the Vascular Closure Device for Femoral Artery Hemostasis in Patients of Femoral Artery Puncture

> **NCT07279220** · NA · NOT_YET_RECRUITING · sponsor: **Shanghai Bomaian Medical Technology Co., Ltd** · enrollment: 238 (estimated)

## Conditions studied

- Femoral Artery Puncture
- Vascular Closure Device
- Hemostasis

## Interventions

- **DEVICE:** Vascular Closure Device Manufactured by Shanghai Bomaian Medical Technology Co., Ltd.
- **DEVICE:** MynxGrip Vascular Closure Device Manufactured by Cordis US Corp

## Key facts

- **NCT ID:** NCT07279220
- **Lead sponsor:** Shanghai Bomaian Medical Technology Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-29
- **Primary completion:** 2026-03-02
- **Final completion:** 2026-05-15
- **Target enrollment:** 238 (ESTIMATED)
- **Last updated:** 2025-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07279220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07279220, "Safety and Effectiveness of the Vascular Closure Device for Femoral Artery Hemostasis in Patients of Femoral Artery Puncture". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT07279220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*